Go to deals
Other Industries

Crusader Resources Limited has raised funds and has dual listed on AIM

Crusader Resources Limited (Crusader) has raised funds and has dual listed on AIM.

Crusader is focused on the exploration and development of gold assets in Brazil. Currently, the company has a portfolio of three highly prospective gold assets in Brazil: Borborema, located in Currais Novos, in the state of Rio Grande de Norte; Juruena, located in Nova Bandeirantes, in the state of Mato Grosso in central Brazil; and Novo Astro, 25 km southeast of Juruena, in the state of Mato Grosso in central Brazil.

Oaklins Smith & Williamson, based in the UK, acted as Nominated Advisor (Nomad) on the share placing.

Talk to the deal team

Brian Livingston

Managing Director
London, United Kingdom
Oaklins Evelyn Partners

Related deals

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Construction & Engineering Services

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland

Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.

Learn more
Duke Capital Limited has completed a fundraising
Financial Services

Duke Capital Limited has completed a fundraising

Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more